What is the correct way to give regular insulin (Actrapid) 6 units intravenously together with a 25 g bolus of 25% dextrose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Administration of Regular Insulin (Actrapid) 6 Units with 25g Dextrose

Administer 6 units of regular insulin (Actrapid) intravenously as a slow push, followed immediately by 25g of dextrose (50 mL of 50% dextrose solution) as an IV bolus, then monitor blood glucose hourly for at least 4-6 hours to detect hypoglycemia.

Administration Protocol

Immediate Administration Steps:

  • Draw up 6 units of regular insulin (Actrapid) in a syringe
  • Administer the insulin slowly IV push through established venous access
  • Immediately follow with 25g dextrose given as 50 mL of 50% dextrose solution IV push 1
  • Administer the dextrose slowly - the rate of administration matters, as rapid administration of concentrated dextrose has been associated with cardiac complications 2

Critical Monitoring Requirements:

  • Check blood glucose before administration to establish baseline 1
  • Monitor blood glucose hourly for 4-6 hours minimum after insulin administration 3
  • The insulin's duration of action exceeds that of the dextrose bolus, creating ongoing hypoglycemia risk 3

Important Clinical Considerations

High-Risk Populations for Hypoglycemia:

Patients at increased risk for developing hypoglycemia with this regimen include those with:

  • Baseline blood glucose <110 mg/dL - these patients had significantly higher hypoglycemia rates 4
  • No diabetes mellitus - non-diabetic patients are at substantially higher risk 3
  • Impaired renal function (CrCl <30 mL/min or dialysis-dependent) 5
  • Female gender and lower body weight 3

Evidence on Hypoglycemia Risk:

Research demonstrates that 22-26% of patients develop hypoglycemia (blood glucose <70 mg/dL) after receiving 10 units insulin with 25g dextrose 6, 7. The median blood glucose reduction is approximately 24 mg/dL, but this is highly variable 6. Patients who develop hypoglycemia typically see their glucose drop from a median of 110 mg/dL to 52 mg/dL 6.

Strategies to Reduce Hypoglycemia Risk:

If the patient has baseline glucose <110 mg/dL or no diabetes:

  • Consider using 50g of dextrose instead of 25g - this significantly reduces hypoglycemia in these populations without causing problematic hyperglycemia 4
  • Alternatively, consider reducing insulin dose to 5 units instead of the traditional 10 units 3

For high-risk patients with impaired renal function:

  • The most effective approach is administering 250 mL of 10% dextrose as a continuous infusion over 2 hours in addition to the initial 50 mL dextrose 50% bolus - this reduced hypoglycemia rates from 20% to 6% in one study 5

Common Pitfalls to Avoid:

  • Do not rely on 4-hourly glucose monitoring - hypoglycemia rates exceed 10% with this frequency 2
  • Do not assume a single dextrose bolus is sufficient - hypoglycemia commonly occurs 60 minutes after insulin and may persist for 2+ hours 5
  • Do not administer concentrated dextrose too rapidly - this has been associated with cardiac arrest and hyperkalemia 2
  • Do not skip the pre-treatment glucose check - baseline glucose is the strongest predictor of hypoglycemia risk 6

Alternative Dosing Considerations:

The FDA label indicates that for insulin-induced hypoglycemia treatment, 10-25g of dextrose (20-50 mL of 50% dextrose) is usually adequate, with repeated doses potentially needed in severe cases 1. However, when using insulin therapeutically (as in hyperkalemia management), the evidence suggests:

  • Titrated dextrose approach: Some protocols recommend 5g aliquots (10 mL of 50% dextrose) repeated as needed rather than large boluses to avoid overcorrection 2
  • 10% dextrose infusion: Administering dextrose as a prolonged infusion (250 mL of 10% dextrose over 2 hours) appears at least as effective as bolus dosing in preventing hypoglycemia 7

Documentation and Follow-up:

  • Document baseline glucose, time of insulin/dextrose administration, and all subsequent glucose values
  • Ensure nursing staff are aware of the need for hourly glucose monitoring
  • Have rescue dextrose readily available at bedside
  • If hypoglycemia develops without clear cause, reduce subsequent insulin doses by 10-20% 8

References

Related Questions

For a 120‑kg patient receiving a PIVOT 1.5% dextrose infusion at 70 mL/h and an insulin infusion at 18.5 U/h, how should I discontinue the PIVOT at midnight and start a D5LR (5% dextrose in lactated Ringer’s) infusion that maintains the same insulin delivery?
How should I prepare and administer a 50 mL 50 % dextrose solution with 10 units of regular insulin to be infused over 30 minutes?
How should I adjust the total insulin dose when a patient receiving an intravenous insulin infusion is also receiving an intravenous dextrose infusion?
In which clinical conditions can dextrose and insulin be administered simultaneously?
Why is 50% dextrose (D50) administered together with regular insulin in the management of hyperkalemia?
For a 27-year-old postoperative patient with neck pain who has been taking oxycodone for approximately one month, how long should the oxycodone be continued?
Can a patient with a paradoxical reaction to diphenhydramine (Benadryl) and pseudoephedrine (Sudafed) safely take hydroxyzine?
What are the possible causes of hair loss in a 66-year-old woman?
Are there any safer sleep medications similar to Ambien (zolpidem) that can be taken on an as‑needed basis instead of nightly?
How should I describe a mild enlargement of the hepatic fissure region with the falciform ligament appearing as a tubular structure representing a recanalized umbilical vein that shows a patent lumen on gray‑scale imaging but no color‑Doppler signal?
In a patient with a dual-chamber pacemaker who has undergone atrioventricular nodal reentrant tachycardia (AVNRT) ablation, can the metoprolol dose be increased?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.